AngioDynamics, Inc.

AngioDynamics, Inc.

AngioDynamics, Inc.

Overview
Date Founded

1992

Headquarters

14 Plaza Drive, Latham, NY, 12110, USA

Type of Company

Public

Employees (Worldwide)

800

Industries

Medical Products & Equipment
Computer Software
Appliances & Electronics
Hospitals & Patient Services

Company Description

AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.

Contact Data
Trying to get in touch with decision makers at AngioDynamics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer, Vice President & Controller

Executive Vice President & Chief Financial Officer

Senior Vice President & General Manager, Vascular Access

Senior Vice President & General Manager, Vascular Access

Senior Vice President & General Manager, Vit

Senior Vice President of Global Operations & R&D

Senior Vice President, Quality & Regulatory Affairs

Senior Vice President, Business Development

Senior Vice President of Business Development

Paths to AngioDynamics, Inc.
Potential Connections via
Relationship Science
You
AngioDynamics, Inc.
Owners & Shareholders
Details Hidden

Systematic Financial Management (SFM) specializes in the management of value portfolios across the market-cap spectrum. The firm manages three distinct investment disciplines to help investors pursue specific value opportunities. Their Catalyst Value, Free Cash Flow Value and Disciplined Value strategies each employ unique, well-defined investment methodologies that leverage SFM's proprietary research to achieve the strategy’s investment objectives. The firm's investment approach is based on the use of both fundamental and quantitative research.SFM's Catalyst Value discipline includes the following portfolio strategy offerings: Large Cap Value, Mid Cap Value, SMID Cap Value, and Small Cap Value Select (All Cap) Equity. Systematic’s Free Cash Flow Value discipline includes the following portfolio strategy offerings: Small Cap, Small Cap Focus, and SMID Cap. Systematic’s Disciplined Value strategies include the following portfolio offerings: Small Cap Equity and International Equity.

Details Hidden

Lapides Asset Management offers value-oriented portfolios of smaller-cap companies including mid-cap, small-cap and micro-cap. They invest in companies with market-cap ranging from $50 million to $10 billion. Lapides is a single strategy firm that offers one investment process segregated into Micro Value, Concentrated Smaller Value and Focused Small/Mid Value products. Each offering is managed in commingled limited partnerships or separate accounts, depending upon the account size and the client's preference.Their approach to value investing focuses on higher quality businesses that have disappointed shareholders, that have fallen out of favor or that have become misunderstood. Lapides research is global in nature to better understand the underlying businesses that comprise these corporations. Equities they buy as value investments are often sold to growth-oriented investors, at much higher valuations.

Details Hidden

Parian Global Management aims to provide superior long-term returns to its clients with minimal correlation to the broader equity and bond markets by trading both long and short a portfolio of securities – primarily North American and non-US listed equities, and equity options – utilizing a fundamental, research-driven approach. The firm believes that the strategy, with generally low net exposure and moderate leverage, will translate into strong returns over a rolling multi-year timeframe while protecting capital regardless of market environment.

Recent Transactions
Details Hidden

AngioDynamics, Inc. purchases Eximo Medical Ltd. from Incentive Incubator Ltd., A.M. Accelmed Management (2009) Ltd., Accelmed Ventures

Details Hidden

Medline Industries, Inc. purchases Angiodynamics, Inc. /NAMIC Fluid Management Bus from AngioDynamics, Inc.

Details Hidden

AngioDynamics, Inc. purchases Radiadyne LLC

Transaction Advisors
Legal Advisor

Advised onAngioDynamics, Inc. issued Up to USD Common Stock

Auditor

Advised onAngioDynamics, Inc. issued USD Common Stock

Public Relations

Advised onAngioDynamics, Inc. purchases Microsulis Medical Ltd.

Co-Chair, Corporate Group

Advised onMedline Industries, Inc. purchases Angiodynamics, Inc. /NAMIC Fluid Management Bus from AngioDynamics, Inc.

Legal Advisor

Advised onMedline Industries, Inc. purchases Angiodynamics, Inc. /NAMIC Fluid Management Bus from AngioDynamics, Inc.

Public Relations

Advised onAngioDynamics, Inc. purchases Vortex Medical, Inc.

Advisors & Consultants
Legal Advisor

Partner at Sidley Austin LLP

Advisor

Senior Vice President & Chief Financial Officer at Avanos Medical, Inc.

Key Stats and Financials As of 2020
Market Capitalization
$472M
Total Enterprise Value
$384M
Earnings Per Share
$-4.39
Revenue
$264M
Net Profit
$-167M
EBITDA
$9.45M
EBITDAMargin
3.58%
Total Debt
$50.4M
Total Equity
$455M
Enterprise Value / Sales
1.45x
Enterprise Value EBITDAOperating
39.47x
TEVNet Income
-2.3x
Debt TEV
0.13x
Three Year Compounded Annual Growth Rate Of Revenue
-9.08%
Five Year Compounded Annual Growth Rate Of Revenue
-5.05%
Non-Profit Donations & Grants
Investors
Details Hidden

Co-Founder at Avista Capital Partners

Suppliers
Medical Components, Inc. Medical Products & Equipment | Harleysville, PA

Medical Components, Inc. manufactures and supports cutting-edge vascular access devices. Its products include needles, repair kits, dilators, guidewires, sheath dilators, and trocars and tunnelers for acute, long term, and short term hemodialysis, as well as central vein infusion and peritoneal dialysis applications. The company was founded in 1978 and is headquartered in Harleysville, PA.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Boston Scientific Corporation Medical Products & Equipment - Marlborough, MA

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Medtronic Plc Medical Products & Equipment - Dublin, Irl

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by AngioDynamics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of AngioDynamics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and AngioDynamics, Inc..